<div id="readability-page-1"><p>Caleres (NYSE:CAL - Get Free Report) announced its earnings results on Tuesday. The textile maker reported $0.67 earnings per share for the quarter, missing the consensus estimate of $0.75 by ($0.08), Zacks reports. The firm had revenue of $790.05 million for the quarter, compared to the consensus estimate of $768.59 million. Caleres had a net margin of 2.26% and a return on equity of 11.91%. The company's quarterly revenue was up 6.6% compared to the same quarter last year. During the same period in the prior year, the business earned $1.23 EPS.  Caleres updated its FY 2025 guidance to 0.550-0.60 EPS.</p><h2>Caleres Stock Up 2.1%</h2><ul><li>Viasat Drops 29%: Falling Knife or Moonshot Bargain?</li></ul><p>Shares of CAL opened at $13.61 on Tuesday. The firm has a market cap of $460.49 million, a price-to-earnings ratio of 7.78 and a beta of 0.73. The company's fifty day moving average is $12.03 and its 200-day moving average is $13.45. Caleres has a 12 month low of $9.54 and a 12 month high of $28.27. </p><h2>Institutional Inflows and Outflows</h2><p>A number of institutional investors have recently made changes to their positions in CAL. AQR Capital Management LLC boosted its position in shares of  Caleres by 143.2% in the first quarter. AQR Capital Management LLC now owns 90,546 shares of the textile maker's stock valued at $1,560,000 after acquiring an additional 53,320 shares during the period.  Empowered Funds LLC raised its stake in  Caleres by 4.2% during the 1st quarter. Empowered Funds LLC now owns 162,814 shares of the textile maker's stock valued at $2,805,000 after purchasing an additional 6,502 shares during the last quarter.  UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in  Caleres by 4.1% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 105,137 shares of the textile maker's stock valued at $1,812,000 after purchasing an additional 4,175 shares during the period.  Franklin Resources Inc. grew its position in  Caleres by 5.6% in the 2nd quarter. Franklin Resources Inc. now owns 18,902 shares of the textile maker's stock worth $231,000 after purchasing an additional 1,007 shares during the last quarter.  Finally, Rhumbline Advisers increased its holdings in shares of  Caleres by 2.4% during the 2nd quarter. Rhumbline Advisers now owns 99,677 shares of the textile maker's stock worth $1,218,000 after purchasing an additional 2,352 shares during the period. 98.44% of the stock is owned by institutional investors. </p><h2>Analyst Ratings Changes</h2><ul><li>3 Late January Earnings Plays With Pop Potential</li></ul><p>Several equities analysts have recently issued reports on the stock. Zacks Research raised shares of Caleres from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research note on Tuesday, November 4th. Weiss Ratings  reaffirmed a &#34;sell (d+)&#34; rating on shares of Caleres in a report on Wednesday, October 8th. Two research analysts have rated the stock with a Hold rating and one  has issued  a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of &#34;Reduce&#34; and a consensus target price of $14.00.</p><p><b>Read Our Latest Analysis on Caleres</b></p><h2>About Caleres</h2> (Get Free Report)<p>Caleres, Inc engages in the retail and wholesale of footwear business in the United States, Canada, East Asia, and internationally. It operates through Famous Footwear and Brand Portfolio segments. The company offers licensed, branded, and private-label athletic, casual, and dress footwear products. The company provides brand name athletic, casual, and dress shoes, including Nike, Skechers, adidas, Vans, Crocs, Converse, Puma, Birkenstock, New Balance, Under Armour, Dr.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Caleres</li><li>Using the MarketBeat Dividend Tax Calculator</li><li>Why These 3 Automotive &amp; Industrial Chip Stocks Just Soared</li><li>What Investors Must Know About Over-the-Counter (OTC) Stocks</li><li>Top 5 Highest-Rated Dividend Stocks, According to MarketBeat</li><li>Stock Average Calculator      </li><li>What Dollar Tree’s Surge and Home Depot’s Slide Say About Consumer Health</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNBTA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="325" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNBTA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Caleres Right Now?</h2><p>Before you consider Caleres, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Caleres wasn't on the list.</p><p>While Caleres currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Caleres (NYSE:CAL) reported quarterly earnings of $0.67 per share, missing analysts' expectations by $0.08. Revenue was $790.05 million, exceeding estimates of $768.59 million, and up 6.6% year-over-year. The company updated its FY 2025 guidance to 0.550-0.60 EPS. Institutional investors have adjusted their positions in Caleres, with 98.44% of the stock owned by them. Analysts have mixed ratings, with a consensus target price of $14.00.</p>

Caleres (NYSE:CAL) Releases Earnings Results, Misses Expectations By $0.08 EPS